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Abstract Approximately 9 million cases of tuberculosis (TB)
are reported annually and half a million occur in children
<15 years of age. Globally, TB notifications in children have
been neglected for decades although childhood TB may repre-
sent a sentinel for ongoing transmission. Data included in this
study were collected from the TB database of the Swiss Federal
Office of Public Health, which includes culture-confirmed TB
and/or cases treated with ≥3 anti-mycobacterial drugs. Data from
all children <15 years of age reported between 1996 and 2011
were analyzed. A total of 320 cases of TB (166 cultures con-
firmed, 5 confirmed by nucleic acid amplification, 149 other
than definite cases) were reported with an overall incidence rate
of 1.6 per 100,000 children (range 1.2–2.2). A total of 154
(48 %) children were younger than 5 years of age and 141
(44 %) were born in Switzerland. Children below 5 years of
age were more likely to be Swiss-born compared to children
aged 10 to 14 years (74 % versus 26 %). When analyzing the
country of origin, only 55 children (17 %) were of Swiss origin.
Of all children with foreign origin, 117 (47 %) were from a
country within the WHO European Region. In 288 (90 %) of all
notified cases, the site of disease was the lung. Mycobacterial
culture was positive in 166 cases (51.9 %) with 1.8 % multi-
drug-resistance. The overall incidence of childhood TB disease
reported in Switzerland remained stable over a 16-year period
with a remarkable high rate of very young patients of foreign
origin. Only half of the reported cases were culture confirmed,
highlighting the need for better diagnostic tests in childhood TB.
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Introduction
Worldwide, approximately 9 million cases of tuberculosis
(TB) are reported annually and it is estimated that half a
million occur in children <15 years of age [23]. The greatest
burden of TB is reported in sub-Saharan Africa and Asia while
cases from the World Health Organization (WHO) European
region represent approximately 5% of all TB cases worldwide
[9, 23]. Globally, TB incidence rates are declining. However,
international migration influences TB epidemiology resulting
in an increase of TB notification rates in some European
countries including Malta, Iceland, Cyprus, Sweden and the
UK since 2004 [12, 13]. In the UK, the majority (61 %) of TB
cases reported in 2004 occurred in foreign-born residents [1].
While in adults, epidemiological data of TB have been
collected and reported by the WHO since the 1990s, special
consideration and reporting of childhood TB has only been
incorporated in the most recent WHO report [13]. Challenges
in the diagnosis of TB in children and a high proportion of
smear-negative cases have led to underreporting. Consequent-
ly, childhood TB was often not prioritised by national control
programmes and reliable epidemiological data are scarce [1,
10]. TB generally results from recent transmission from a
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smear-positive contact, mainly household or school contacts
[2]. Therefore, analysis of epidemiological data in children is
important as it may represents a sentinel for ongoing trans-
mission and it also serves as a measure of the overall TB
control [1].
In Switzerland, epidemiological data of TB in children
have been collected for more than a decade but were never
analyzed separately in detail [5]. The aim of this study was to
analyze epidemiological and clinical data of childhood TB in
Switzerland and compare results with data from other studies
in countries with low TB incidence.
Patients and methods
Data were collected from the TB database of the Swiss Federal
Office of Public Health (FOPH) which included all children
with confirmed TB (positive culture) and those with presumed
TB treated with three or more anti-mycobacterial drugs. TB
notifications in Switzerland are mandatory for both microbi-
ology laboratories and clinicians initiating anti-tuberculous
treatment. Microbiology laboratories have to report to the
FOPH and the regional health authority (cantonal physician);
clinicians have to report to the cantonal physician, who for-
wards this notification to the FOPH. All notifications are
collected in a centralized database, information is linked by
personal identifiers and entered as one record per case. Results
from all children below 15 years of age reported from 1996 to
2011 were included for this study.
Swiss origin was defined as the country of birth being
Switzerland and/or Swiss nationality. In the case of evidence
for foreign birth or foreign nationality, the case was defined as
foreign origin. If both the country of birth and nationality were
unknown, the origin was defined as unknown.
For this study, confirmed TB disease was defined as a
positive result from culture or nucleic acid amplification tech-
nique (NAAT) of sputum, bronchoalveolar lavage fluid, gastric
aspirate, lymph node, bone biopsy, joint fluid, cerebrospinal
fluid with a species within the Mycobacterium tuberculosis
complex (Mycobacterium tuberculosis, Mycobacterium bovis
and Mycobacterium africanum). Major sites of disease were
grouped into pulmonary (lung parenchyma, tracheobronchial
tree, intrathoracic lymph nodes), pleural, extrathoracic lymph
nodes, bones and joints, gastrointestinal, meningitis, and dis-
seminated TB according to the clinician's assessment. All other
sites of disease not further specified were grouped into
unknown.
Results
A total of 320 (166 culture confirmed, 5 NAAT confirmed,
149 treated with ≥3 anti-mycobacterial drugs) cases of TB in
children below 15 years of age were reported over a 16-year
period. The overall mean incidence rate was 1.6 (median 1.7,
range 1.2–2.2) per 100,000 children per year, which varied
from year to year but without an obvious trend over time
(Fig. 1).
The mean age of all children with TB was 5.9 with a
standard deviation (SD) of 4.7 years (median 5.0, interquartile
range (IQR) 2.0 to 10.0 years) and 165 (52 %) were female
(Fig. 2). A total of 154 cases (48 %) were reported in children
below 5 years of age.
When analyzing the country of birth, 141 (44 %) children
were foreign-born, 141 (44 %) children were Swiss-born, and
in 38 cases (12 %), the place of birth was unknown (Fig. 3a).
Children below 5 years of age were more likely to be Swiss-
born compared to children aged 10 to 14 years (67 % versus
15 %, respectively). However, when analyzing country of
origin, only 55 (17 %) children were of Swiss origin, 262
(82 %) were of foreign origin and in 3 (1 %) children origin
was unknown. Of all children with foreign origin and known
citizienship, 117 (47 %) were from a country within the WHO
European Region (Table 1). The mean age of all children with
Swiss origin was 4.2 years (median 3, range 0–13), the mean
age of all children with foreign origin was 6.3 years (median
5.5, range 0–14).
When analyzing the site of infection of all reported cases,
pulmonary TB was found in 288 (90 %) of the reported TB
cases, of which 26 were classified as hilar lymphadenopathy.
Of all children with pulmonary TB, 145 (50.3 %) were report-
ed in children younger than 5 years of age. The second most
commonly affected site were extra-thoracic lymph nodes with
16 (5 %) cases. Other reported sites were the central nervous
system (three cases), the pleural space (two cases), bones and
joints (two cases), and one case each in the vertebral column,
Fig. 1 Overall tuberculosis
incidence rate in children below
15 years of age notified in
Switzerland
458 Eur J Pediatr (2014) 173:457–462
gastrointestinal tract and disseminated TB. In six cases, the
site of disease was unknown.
Mycobacterial culture was positive in 166 cases (51.9 %);
Mycobacterium tuberculosis in 153 cases andMycobacterium
africanum in 3 cases were isolated. In 10 culture-positive
cases, the mycobacterial species was not reported. Culture
was reported as negative in four cases (1.3 %), and in 150
cases (46.9 %), the result of the culture was reported as
unknown at the time of notification but remained negative.
The mean age of all children with a positive culture was 6.1
(SD 5.0) years (median 5.0 years, IQR 1 to 11). In the age
group 0 to 4 years, 51.3 % were culture positive, in the 5- to 9-
year group, 46.2 % and in the 10- to 14-year group, 58.0 %.
When we analyzed the site of infection only in culture-
confirmed cases, 147 of 166 (89 %) were classified as pulmo-
nary TB and 4 of 166 (5 %) were classified as extra-thoracic
lymph node TB.
Monoresistance was reported for isoniazid in nine isolates
and for rifampicin and ethambutol in three isolates each. Only
three cases (1.8 %) were reported to be multi-drug-resistant
(MDR) TB, defined as resistant to both isoniazid and
rifampicin.
Discussion
Incidence of childhood TB in Switzerland remains low with a
rate of 1,6 per 100,000. However, calculation of incidence
rates represents approximations as currently Swiss population
statistics do not include asylum seekers. Between 1996 and
2011, an estimated 75,000 to 100,000 individuals were living
in Switzerland applying for asylum which until 2010 were not
included in the population statistics, and therefore, true inci-
dence rates may be lower. Similar low incidence rates have
been reported in England and Wales with 4.3 TB cases per
100,000 children per year between 1999 and 2006 [1]. This is
in contrast to incidence rates from high-burden countries, such
as South Africa, with an estimated TB incidence rate of 237
per 100,000 children [13]. TB notification rates for children in
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Fig. 2 Age distribution of all children below 15 years of age with
tuberculosis reported in Switzerland between 1996 and 2011
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Fig. 3 Country of birth (a) and
country of origin (b) in children
aged 0–4 years (n =154), 5–
8 years (n=78) and 10–14 years
(n =88) notified with tuberculosis
in Switzerland
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Switzerland were lower compared to the overall incidence
rates, which were reported to be 7.1 per 100,000 inhabitants
in 2009 [4]. Similar observations were reported in other Eu-
ropean countries with three to four times higher incidence in
all age groups above 14 years of age [17].
In our study, almost half of the notified patients were below
5 years of age. This is in accordance with data from the
European Union with approximately 50 % of TB cases in
children reported below the age of 5 years [17].
A similar number of children with TBwere Swiss-born and
foreign-born; however, the proportion of Swiss-born children
was higher in the group aged 0 to 4 years. Importantly, many
of the Swiss-born children had foreign citizenship, and over-
all, only one in five children with TB in Switzerland were of
Swiss origin. Children with Swiss origin were younger than
those with foreign origin and two thirds of all children of
Swiss origin with TBwere under 5 years of age. Similar trends
have been found in other low-TB-incidence countries show-
ing that the largest proportion of children with TB aged below
5 years were nationally born [1, 17, 22]. In our study, a more
detailed analysis including the country of birth and country of
origin shows that a large proportion of these children catego-
rized as nationally born descend from foreign-born parents.
Their parents likely have immigrated recently from a high-
TB-incidence country which explains the increased risk of
transmission and TB disease in their children [16, 22].
Older children with TB notified in Switzerland are more
likely to be of foreign origin. Given the low incidence of TB in
Switzerland, the most likely explanation is acquisition of TB in
their country of origin either before they arrived in Switzerland,
during recent travel to a high-TB-incidence country, or from
friends and relatives with a recent diagnosis of TB disease [15].
Switzerland has abandoned the universal TB screening and
introduced a questionnaire-based case finding of all immi-
grants in 2006, and therefore, routine TST/IGRAs and chest
X-rays at first entry are no longer done [18]. Unfortunately,
the current database does allow analysis on the interval be-
tween arrival in Switzerland and TB notification.
Most patients of foreign origin were from the former Yu-
goslavia or from Somalia, the latter with estimated TB
Table 1 Countries of citizenship
from the 262 children with for-
eign origin
a Children with foreign origin,
who have obtained Swiss citizen-
ship or children with Swiss citi-
zenship who were born abroad
Country No. of patients (%) Country No. of patients (%)
Serbia 62 (23.7) Sudan 2 (0.8)
Somalia 30 (11.5) Senegal 2 (0.8)
Portugal 14 (5.3) Papua New Guinea 1 (0.4)
Switzerlanda 12 (4.6) Sierra Leone 1 (0.4)
Albania 12 (4.6) Togo 1 (0.4)
Eritrea 11 (4.2) Guinea-Bissau 1 (0.4)
Bosnia Herzegovina 7 (2.7) Dominic. Republic 1 (0.4)
Mazedonia 7 (2.7) Russia 1 (0.4)
Turkey 6 (2.3) Greece 1 (0.4)
China and Tibet 6 (2.3) Spain 1 (0.4)
Angola 6 (2.3) France 1 (0.4)
Kongo (Brazzaville) 4 (1.5) Ukraine 1 (0.4)
Sri Lanka 4 (1.5) Iran 1 (0.4)
Côte d'Ivoire 4 (1.5) Afghanistan 1 (0.4)
Iraq 3 (1.1) Japan 1 (0.4)
Pakistan 3 (1.1) Thailand 1 (0.4)
Croatia 3 (1.1) China (Taiwan) 1 (0.4)
Kenia 3 (1.1) Armenia 1 (0.4)
Ruanda 3 (1.1) Georgia 1 (0.4)
Tschad 3 (1.1) Ethiopia 1 (0.4)
Romania 2 (0.8) Ghana 1 (0.4)
Italy 2 (0.8) Mali 1 (0.4)
India 2 (0.8) Brazil 1 (0.4)
Cambodia 2 (0.8) Chile 1 (0.4)
Vietnam 2 (0.8) Ecuador 1 (0.4)
Cameroun 2 (0.8) Peru 1 (0.4)
Guinea 2 (0.8) Unknown/stateless 15 (5.7)
Madagascar 2 (0.8)
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incidence rates of 150 per 100,000 inhabitants [23]. Although
immigration to Switzerland increased during the study period
with over 20 % foreign residents in 2011, incidence rates of
childhood TB remained stable during the study period [6].
One possible explanation is that there has been a slight shift
towards an origin from a low-TB-incidence country in people
immigrating to Switzerland [6]. However, incidence rates in
adults have increased between 2007 and 2011 [4, 5]. It is
therefore possible that increased awareness, early treatment
of adults/parents and meticulous contact tracing and preven-
tative therapy with isoniazid have prevented the transmission
of TB from adults to children and progression of TB infection
to disease in children. Unfortunately, epidemiological data on
children with latent TB is not systematically collected, and
therefore, it remains elusive if more children have been treated
for latent TB in the same time period [20].
In our study, TB was culture-confirmed in over half of all
reported cases. This proportion of culture-confirmed cases is
considerably higher compared to that reported across Europe
ranging from 15 to 20 % [1, 17]. However, a Swedish study
including 147 children below 18 years of age showed compa-
rable results [12]. The higher rate of microbiological confirma-
tion in some countries can be explained by underreporting of
culture-negative TB cases in other countries. It may, however,
reflect the willingness of both clinicians and families to collect
samples from children with suspected TB for microbiological
confirmation combined with an optimal mycobacterial detec-
tion rate of well-equipped laboratories in Switzerland. The
differences in proportions of culture confirmed cases in children
in different countries may also reflect over-reporting, which is
rarely discussed. However, until more accurate diagnostic tests
for TB are available for children, both underreporting and over-
reporting will occur [7, 8]. The low incidence of MDR TB is
comparable to other pediatric studies and reflects MDR TB
rates in adult patients in Switzerland [1, 3, 5, 12]. Nevertheless,
MDR TB remains of concern as experience for treatment of
these children is limited as a result of few children being
diagnosed with MDR TB in Switzerland. In addition, optimal
management of children exposed to adults with MDR TB is
unclear and guidance on a national and international level is
consequently based on expert opinion [11, 19, 21].
As a result of the limited set of variables collected by the
FOPH according to European recommendations, several other
potentially interesting epidemiological and clinical data could
not be investigated [14]. This includes the rates of infection
with the Human Immunodeficiency Virus, Bacille Calmette–
Guérin (BCG) vaccination and detailed results from NAAT
and immuno-diagnostic tests including the tuberculin skin test
and/or interferon gamma release assays. We are also unable to
examine underreporting or over-reporting as data of TB in
children in Switzerland is currently not collected in any other
systematic way. However, the Swiss Paediatric Surveillance
Unit has recently accepted to include TB into their
surveillance system. This will allow more detailed analysis
of the epidemiology of children with TB in Switzerland and
also enhance analysis of potential underreporting or over-
reporting in the future.
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